Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 15 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Sterile Water for Injection with BFS Technology

The objective of formulating and compounding sterile preparations is to provide adosage form of a labeled drug, in the stated potency that is safe to use if administeredproperly.Water for InjectionWater for injection is purified by distillation or reverse osmosis and is free of pyrogens (bacterial substance that can produce fever).Sterile water for injection USP is sterilized and packaged in single-dose containers not exceeding 1000 ml.Bacteriostatic water for injection is sterilized and contains one or more bacteriostatic agents in a container no larger than 30 ml. India’s pharmaceutical sector has seen unwavering growth in the past few years, going up to 23 billion USD in 2012 from 23 billion USD in 2002. Various industry reports suggest that the pharmaceutical sector in India has been growing consistently at the rate of 13-14% every year since the last five years.India has an organized pharmaceutical market of its own, which is being considered as a potential partner by other countries. The Indian Pharma Market is ranked number 3 in terms of volume and 10thin terms of market value.As a whole it is a good project for new entrepreneurs to invest. Few Indian Major Players are as under • Abaris Healthcare Pvt. Ltd. • AhlconParenterals (India) Ltd. • Core Laboratories Ltd. • Infutec Healthcare Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Surgicals Ltd. • Punjab Formulations Ltd. • Shree Krishna Keshav Laboratories Ltd.
Plant capacity: Ampoules 5 ml Size: 300,000 Th. Nos./annum Ampoules 10 ml Size: 260,000 Th. Nos./annum Ampoules 20 ml Size: 120,000 Th. Nos./annumPlant & machinery: Rs 607 lakhs
Working capital: -T.C.I: Cost of Project: Rs 917 lakhs
Return: 28.00%Break even: 55.00%
Add to Inquiry Add to Inquiry Basket

Soft Gelatin Capsules

Soft gelatin (also called softgel or soft elastic) capsules consist of one piece hermetically-sealed soft shells. Soft gelatin capsules are prepared by adding a plasticizer, such as glycerin or polyhydric alcohol (e.g., sorbitol), to gelatin. The plasticizer makes gelatin elastic. Soft gelatin capsules come in various shapes such as spherical, elliptical, oblong, and special tube shapes with and without twist off. They can contain non-aqueous liquids, suspensions, pasty materials, or dry powders. The term soft gelatin capsules is commonly abbreviated to 'softgels'.Soft gelatin capsules has an advantages over hard gelatin capsules is to make a liquid formulation containing the drug in a one-piece outer gelatin shell. The demand of the soft gel capsules is increasing due to the available customization facilities for the molds and content as per customer needs. The soft gel capsules have many application areas out of which pharmaceutical, cosmetics and health supplements contribute the major shares to the growth of the global soft gel capsules market.The Global Softgel Capsules Market is poised to grow at a CAGR of around 5.4% over the next decade to reach approximately $316.6 billion by 2025.Thus, as an entrepreneur this project offers an exciting opportunity to you. Few Indian Major Players are as under • C J Gelatine Products Ltd • Fortcaps Healthcare Ltd. • Healthcaps India Ltd. • India Gelatine& Chemicals Ltd. • K P Gelatines& Chemicals India Ltd. • Narmada Gelatines Ltd. • Rama Industries Ltd. • Sterling Biotech Ltd.
Plant capacity: 1,800,000 Th.Nos./annumPlant & machinery: Rs 261 lakhs
Working capital: -T.C.I: Cost of Project: Rs 478lakhs
Return: 27.00%Break even: 57.00%
Add to Inquiry Add to Inquiry Basket

I.V. FLUID (Automatic Plant)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenousadministration. I.V. fluids or Intravenous fluids are life saving drugs, which are widely used in surgery, pediatrics, urology, obstetrics and gynecology. They are given mostly to patients suffering from dehydration, diarrhorea, vomiting, gastroenteritis and excessive perspiration. The growth of the global intravenous solutions market is driven by several factors. The increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that are expected to increase the rate of adoption of intravenous solutions among consumers. Thus, due to demand it is a good project for entrepreneurs to invest. Few Indian Major Players are as under • AxaParenterals Ltd. • D.J. Laboratories Pvt. Ltd. • Baxter International Inc. • Amanta Healthcare • Aishwarya Healthcare
Plant capacity: 1,44,00,000 bottles/annumPlant & machinery: Rs 462 lakhs
Working capital: -T.C.I: Cost of Project : Rs 1362lakhs
Return: 27.00%Break even: 66.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Manufacturing Unit (Betalactam and NonBetalactam)

Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form. Beta-lactam antibiotics, including penicillins and the non-penicillin classes, share a basic chemical structure that includes a three-carbon, one-nitrogen cyclic amine structure known as the beta-lactam ring.The side chain associated with the beta-lactam ring is a variable group attached to the core structure by a peptide bond; the side chain variability contributes to antibacterial activity. Various industry reports suggest that the pharmaceutical sector in India has been growing consistently at the rate of 13-14 % every year.India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level.As a whole it is a good project for new entrepreneurs to invest. Few Indian Major Players are as under • AurobindoPharma Ltd. • Arbro Pharmaceuticals Pvt. Ltd. • Bafna Pharmaceuticals Ltd. • Fermenta Biotech Ltd. • Medreich Ltd. • NitinLifesciences Ltd. • Shreya Life Sciences Pvt. Ltd. • Taj Pharmaceuticals Ltd.
Plant capacity: Betalactam Cephalexin Tablets 400 mg: 3,000,000 Nos./annum Betalactam Cephalexin Capsules 400 mg:3,000,000 Nos./annum Betalactam Cephalexin Syrup 50 ml:1,500,000 Nos./annum Betalactam Cephalexin Dry Syrup 30 ml:1,500,000 Nos./annum Betalactam Cephalexin SPlant & machinery: Rs 103 lakhs
Working capital: -T.C.I: Cost of Project: Rs 1452 lakhs
Return: 33.00%Break even: 45.00%
Add to Inquiry Add to Inquiry Basket

Vitamin ‘C’

Vitamin C is a physiological antioxidant of major importance for protection against diseases and degenerative processes caused by oxidative stress. Vitamin C is ubiquitous. It is found throughout the plant and animal kingdoms, where its roles are often not known or are poorly understood. The synthetic vitamin is very widely used as a food additive and therefore has an E number (E300). The global Ascorbic Acid market is expected to witness moderate growth over the forecast period on account of increasing demand from pharmaceutical industry. The majority of ascorbic acid manufactured is used as an antioxidant. The major end-user industries of ascorbic acid are pharmaceuticals, food & beverages, personal care, and others. The pharmaceutical industry is the largest consumer of ascorbic acid. Vitamin C helps to recycle vitamin E. About one-third of the total production of ascorbic acid is used for vitamin preparations in the pharmaceutical industry. The rest is mainly applied as an additive to food and feed to enhance product quality and stability. Vitamin C Market is driven due to rising health awareness and need for healthy lifestyle. Thus, due to demand it is a good project for entrepreneurs to invest. Few Indian major players are as under • Manav Drugs • A.B. Enterprises • TriveniInterchem Pvt. Ltd. • Estrellas Life Sciences Pvt. Ltd. • Akhil Healthcare Private Limited
Plant capacity: 2400 MT/annumPlant & machinery: Rs 123 lakhs
Working capital: -T.C.I: Cost of Project : Rs 563 lakhs
Return: 29.00%Break even: 50.00%
Add to Inquiry Add to Inquiry Basket

Baby Cereal Food

The Baby-cereal-foods is that enriched food which has a requisite level of nutrition. This requisite level is prescribed by various dietitians & physicians for children. Various experts fixed a definite calorific value for infant food & based on this the various mixtures or formulae of foods are developed. Food products are derived from single grains or blends of mixed grains combined with other ingredients for flavour and nutritional fortification. Materials used by various manufacturers in addition to the grains include malt, milk powder, vegetable oil, wheat germ, sugar, cotton seed flour, tri and dicalcium phosphate, dried yeast, a form of iron such as sodium iron pyrophosphate and the vitamin B1 (thiamin), riboflavin and niacin. The baby food market in India is witnessing rapid growth and is growing by 10-12% a year. India has the largest population of 0-4 year old in Asia. Additionally, due to the increasing number of working women, and the increasing parental concerns about nutrition have lead to its growth. Professionally-made food designed to meet the nutrition requirements of babies also address the problems of paucity of time for preparing baby food at home.As a whole it is a good project for new entrepreneurs to invest. Few Indian major players are as under • Continental Milkose (India) Ltd. • Glaxosmithkline Consumer Healthcare Ltd. • Hindustan Foods Ltd. • Kaira District Co-Op. Milk Producers' Union Ltd. • Narayan Agro Foods Ltd. • Natureland Organic Foods Pvt. Ltd. • Nestle India Ltd.
Plant capacity: Baby Cereal Food (Packing in 225 gms Size Packet): 600,000 Kgs/annumPlant & machinery: Rs 35 lakhs
Working capital: -T.C.I: Cost of Project : Rs 82 lakhs
Return: 32.00%Break even: 72.00%
Add to Inquiry Add to Inquiry Basket

Pharmaceutical Manufacturing Unit (Beta-Lactam and Non-Beta Lactam) Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form. Beta-lactam antibiotics, including penicillins and the non-penicillin classes, share a basic chemical structure that includes a three-carbon, one-nitrogen cyclic amine structure known as the beta-lactam ring. The side chain associated with the beta-lactam ring is a variable group attached to the core structure by a peptide bond; the side chain variability contributes to antibacterial activity. Various industry reports suggest that the pharmaceutical sector in India has been growing consistently at the rate of 13-14 % every year. India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. As a whole it is a good project for new entrepreneurs to invest. Few Indian Major Players are as under: • Aurobindo Pharma Ltd. • Arbro Pharmaceuticals Pvt. Ltd. • Bafna Pharmaceuticals Ltd. • Fermenta Biotech Ltd. • Nitin Lifesciences Ltd. • Shreya Life Sciences Pvt. Ltd. • Taj Pharmaceuticals Ltd. Market Outlook The Indian pharmaceuticals market increased at a CAGR of 17.46 per cent during 2005-16 with the market increasing from US$ 6 billion in 2005 to US$ 36.7 billion in 2016 and is expected to expand at a CAGR of 15.92 per cent to US$ 55 billion by 2020. India is the largest provider of generic drugs globally with the Indian generics accounting for 20 per cent of global exports in terms of volume. Of late, consolidation has become an important characteristic of the Indian pharmaceutical market as the industry is highly fragmented. India enjoys an important position in the global pharmaceuticals sector. The Indian pharma industry, which is expected to grow over 15 per cent per annum between 2015 and 2020, will outperform the global pharma industry, which is set to grow at an annual rate of 5 per cent between the same periods. The market is expected to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest pharmaceutical market globally by absolute size. Indian pharmaceutical sector accounts for about 2.4 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms. The Indian pharmaceutical market size is expected to grow to US$ 100 billion by 2025, driven by increasing consumer spending, rapid urbanisation, and raising healthcare insurance among others. Tags Pharma Manufacturing, Pharmaceutical Manufacturing Plant, How to Start Pharmaceutical Manufacturing, Pharmaceutical Manufacturing, How to Start Pharmaceutical Manufacturing Unit in India, Pharmaceutical Manufacturing Business, Pharmaceuticals Manufacturing Industry, Pharmaceutical Manufacturing Unit, Manufacturing of Pharmaceutical, Pharma Manufacturing Unit, Pharmaceutical Industry, Pharmaceutical Production, Pharmaceutical Manufacturing Business Opportunities, Pharmaceutical Production Units, Pharmaceutical Plant, Pharmaceutical Manufacture, Pharmaceutical(Betalactum and Non Betalactum) Manufacturing Equipment, Pharmaceutical Formulation, Pharmaceutical Manufacturing Process, Manufacturing Process of Pharmaceutical, Production of Pharmaceutical(Betalactum and Non Betalactum), Manufacturing Unit of Pharmaceutical, Large Scale Pharmaceutical Manufacturing, Production Plant of Pharmaceutical, Guidelines for Pharmaceutical Production Plants, Method for Manufacturing Pharmaceutical, Process of Manufacturing of Pharmaceutical, Drugs Manufacturing, Production Process of Pharmaceutical, Methods for Manufacture of Pharmaceutical, Pharmaceutical Manufacturing and Process, Pharmaceutical Manufacturing Guide, Production Planning of Pharmaceutical, Pharmaceutical Manufacturing Plan, How to Start Pharmaceutical (Betalactum and Non Betalactum) Manufacturing Business, Starting Pharmaceutical Manufacturing Business, Pharma Industry in India, Business Planning in Pharmaceuticals, Business Plan for Pharmaceutical Manufacturing Plant, Pharmaceutical(Betalactum and Non Betalactum) Manufacturing Business Plan, Pharmaceutical Manufacturing Line, Project Profile on Pharmaceutical Manufacturing, Opportunities in Pharmaceutical Manufacturing, Manufacturing Process of Drugs, Production of Drugs, Beta-Lactam Production, Industrial Production of Beta-Lactam, Beta-Lactam Manufacturing Plant, Manufacturing Unit of Beta-Lactam, How to Start Beta-Lactam Manufacturing Unit, Manufacturing of Non-Betalactum, Non-Betalactum Production, Manufacturing Process of Non-Betalactum, Production of Non-Betalactum, Pharmaceutical Manufacturing Project Ideas, Projects on Small Scale Industries, Small Scale Industries Projects Ideas, Pharmaceutical Manufacturing Based Small Scale Industries Projects, Project Profile on Small Scale Industries, How to Start Pharmaceutical(Beta-lactum and Non-Betalactum) Manufacturing Industry in India, Pharmaceutical Manufacturing Projects, New Project Profile on Pharmaceutical Manufacturing Industries, Project Report on Pharmaceutical(Beta-lactum and Non-Betalactum) Manufacturing Industry, Detailed Project Report on Pharmaceutical(Beta-lactum and Non-Betalactum) Manufacturing, Project Report on Pharmaceutical Production, Pre-Investment Feasibility Study on Pharmaceutical Manufacturing, Techno-Economic Feasibility Study on Pharmaceutical Production, Feasibility Report on Pharmaceutical(Beta-lactum and Non-Betalactum) Manufacturing, Free Project Profile on Pharmaceutical Production Project Profile on Pharmaceutical Manufacturing, Download Free Project Profile on Pharmaceutical(Beta-lactum and Non-Betalactum) Manufacturing, Industrial Project Report, Project Consultant, Project Consultancy, NPCS, Niir, Process Technology Books, Business Consultancy, Business Consultant, Project Identification and Selection, Preparation of Project Profiles, Startup, Business Guidance, Business Guidance to Clients, Startup Project for Pharmaceutical(Beta-lactum and Non-Betalactum) Manufacturing, Startup Project, Startup Ideas, Project for Startups, Startup Project Plan, Business Start-Up, Business Plan for Startup Business, Great Opportunity for Startup, Small Start-Up Business Project, Project Report for Bank Loan, Project Report For Bank Finance, Project Report Format for Bank Loan in Excel, Excel Format of Project Report and CMA Data, Project Report Bank Loan Excel, Detailed Project Plan Reports, Non-Penicillin Beta-Lactam Drugs, Guidance for Beta-Lactam Antibiotics, Betalactam Antibiotics Manufacturing, Beta-Lactams Production, Non Beta Lactam, Manufacturing Beta-Lactam, Production of Beta-Lactam Antibiotics \ CAPACITY Betalactam Cephalexin Tablets 400 mg: 3,000,000 Nos./annum Betalactam Cephalexin Capsules 400 mg:3,000,000 Nos./annum Betalactam Cephalexin Syrup 50 ml:1,500,000 Nos./annum Betalactam Cephalexin Dry Syrup 30 ml:1,500,000 Nos./annum Betalactam Cephalexin Sachet:3,000,000 Nos./annum Non BetalactamCefixime Tablets 400 mg:3,000,000 Nos./annum Non BetalactamCefixime Capsules 400 mg:3,000,000 Nos./annum Non BetalactamCefixime Syrup 50 ml:1,500,000 Nos./annum Non BetalactamCefixime Dry Syrup 30 ml:1,500,000 Nos./annum Non BetalactamCefixime Sachet:3,000,000 Nos./annum
Plant capacity: -Plant & machinery: 103 lakhs
Working capital: -T.C.I: Cost of Project : Rs 1452 lakhs
Return: 33.00%Break even: 45.00%
Add to Inquiry Add to Inquiry Basket

Production of Soft Gelatin Capsules (Softgel Capsules) Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study

Soft gelatin (also called softgel or soft elastic) capsules consist of one piece hermetically-sealed soft shells. Soft gelatin capsules are prepared by adding a plasticizer, such as glycerin or polyhydric alcohol (e.g., sorbitol), to gelatin. The plasticizer makes gelatin elastic. Soft gelatin capsules come in various shapes such as spherical, elliptical, oblong, and special tube shapes with and without twist off. They can contain non-aqueous liquids, suspensions, pasty materials, or dry powders. The term soft gelatin capsules is commonly abbreviated to 'softgels'. Soft gelatin capsules has an advantages over hard gelatin capsules is to make a liquid formulation containing the drug in a one-piece outer gelatin shell. Few Indian Major Players are as under: • C J Gelatine Products Ltd • Fortcaps Healthcare Ltd. • Healthcaps India Ltd. • India Gelatine & Chemicals Ltd. • K P Gelatines & Chemicals India Ltd. • Narmada Gelatines Ltd. • Rama Industries Ltd. • Sterling Biotech Ltd. Market Outlook The Global Softgel Capsules Market is poised to grow at a CAGR of around 5.4% over the next decade to reach approximately $316.6 billion by 2025. The global soft gel capsule market is expected to register a significant CAGR over a forecast period. The increasing demand of the soft gel capsules from the growing cosmetics industry to deliver the cosmeceutical in the form of capsule drives the growth of the global soft gel capsules market. The increasing intake of the supplements through capsules, also boost the demand of the soft gel capsules and drives the global soft gel capsules market. The developments in the soft gel capsules in terms of the outer shell and compatibility with the inner ingredients, also propel the use of soft gel capsules by the pharmaceutical industry and become one of the key factors of the global soft gel capsules market. On the basis of application, the global soft gel capsules market is segmented as follows: • Antacid and anti-flatulent preparations • Anti-anemic preparations • Anti-inflammatory drugs • Antibiotic and antibacterial drugs • Cough and cold preparations • Cardiovascular therapy drugs • Health supplement • Vitamins & dietary supplements Tags Soft Gelatin Capsule Manufacturing, Soft Gelatin Capsule, Softgel Capsules Manufacture, Soft Gelatin Capsules Manufacturing Process, Soft Gelatin Capsules Formulation, Pharmaceutical Capsules Manufacturing, Soft Gelatin Capsules Manufacture, Manufacture of Soft Gelatin Capsules, Softgel Capsule Manufacturing Plant, Softgel Manufacturing, Soft Gelatin Capsule Production, Soft Gelatin Capsule Manufacture, Steps of Softgel Manufacturing, Manufacturing of Soft Gelatin Capsules, How to Make Soft Gelatin Capsules, Process of Manufacturing Soft Gelatin Capsules, Manufacturing Process of Soft Gelatin Capsules, Softgel Manufacturing Formula, Softgel Manufacturing Process, Pharmaceutical Softgel Manufacture, Softgel Manufacturing Line, Capsule Production, Soft Gelatin Capsule Manufacturing in India, Production Process of Soft Gelatin Capsules, Method for Manufacturing Soft Gelatin Capsules, Manufacturing Plant of Soft Gelatin Capsules, Gelatin Capsule Manufacturing Process, Manufacturing Process of Gelatin Capsules, Soft Gelatin Capsules Manufacturing Unit, Production of Soft Gelatin Capsules, Soft Gelatin Capsules Industry, Method for Production of Soft Gelatin Capsules, Process of Manufacturing Softgel, Project Profile on Manufacturing Soft Gelatin Capsules, Production Plant of Soft Gelatin Capsules, Manufacturing Units for Soft Gelatin Capsules, Gelatin Capsule Manufacturing Business, Softgel Capsules Manufacturing Business, Commercial Softgel Production, Soft Gelatin Capsules Manufacturing Business, Softgel Production, Production Planning of Soft Gelatin Capsules, Soft Gelatin Capsules Production, Method for Producing Soft Gelatin Capsules, Business Ideas for Manufacturing of Soft Gelatin Capsules, Soft Gelatin Capsules Production Projects, Soft Gelatin Capsules Production Project Ideas, Projects on Small Scale Industries, Small Scale Industries Projects Ideas, Soft Gelatin Capsules Manufacturing Based Small Scale Industries Projects, Project Profile on Small Scale Industries, How to Start Soft Gelatin Capsules Manufacturing In India, New Project Profile on Soft Gelatin Capsules Production, Project Report on Soft Gelatin Capsules Manufacturing Industry, Detailed Project Report on Soft Gelatin Capsules Production, Project Report on Soft Gelatin Capsules Production, Pre-Investment Feasibility Study on Soft Gelatin Capsules Production, Techno-Economic Feasibility Study on Softgel Production, Feasibility Report on Soft Gelatin Capsules Manufacturing, Free Project Profile on Soft Gelatin Capsules Production, Project Profile on Soft Gelatin Capsules Manufacturing, Download Free Project Profile on Softgel Production, Industrial Project Report, Project Consultant, Project Consultancy, NPCS, Niir, Process Technology Books, Business Consultancy, Business Consultant, Project Identification and Selection, Preparation of Project Profiles, Startup, Business Guidance, Business Guidance to Clients, Startup Project for Soft Gelatin Capsules Production, Startup Project, Startup Ideas, Project for Startups, Startup Project Plan, Business Start-Up, Business Plan for Startup Business, Great Opportunity for Startup, Small Start-Up Business Project, Project Report for Bank Loan, Project Report for Bank Finance, Project Report Format for Bank Loan in Excel, Excel Format of Project Report and CMA Data, Project Report Bank Loan Excel, Detailed Project Plan Reports
Plant capacity: 1,800,000 Th.Nos./annumPlant & machinery: 261 Lakhs
Working capital: -T.C.I: Cost of Project 478 Lakhs
Return: 27.00%Break even: 57.00%
Add to Inquiry Add to Inquiry Basket

Production of Paracetamol (Acetaminophen) Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

Paracetamol, also known as acetaminophen or APAP, is a medication used to treat pain and fever. It is typically used for mild to moderate pain. The quality of the evidence regarding the use for fever relief in children is poor. It is often sold in combination with other ingredients such as in many cold medications. In combination with opioid pain medication, paracetamol is used for more severe pain such as cancer pain and after surgery. It is typically used either by mouth or rectally but is also available intravenously. Effects last between two and four hours. Paracetamol lacks anti-inflammatory action in rheumatic disorders. However, it is less toxic than the Aspirin and does not produce anemia and liver damage, which sometimes result from the continued use of acetanilide and acetophenotidine. It is also an important intermediate in the manufacture of other pharmaceuticals like the antimalarial amodiaquine. Few Indian Major Players are as under: • Alta Laboratories Ltd. • Granules India Ltd. • HaffkineAjintha Pharmaceuticals Ltd. • Pan Drugs Ltd. Market Outlook The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in terms of value. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in an aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. Global acetaminophen market was valued at around USD 801.3 million in 2014 and is expected to reach USD 999.4 million in 2020, growing at a CAGR of around 3.8% between 2015 and 2020. In terms of volume, the global acetaminophen market stood at above 149.3 kilo tons in 2014. The global paracetamol market is expected to reach US$1,049.7 mn by 2022 as compared to its valuation of US$900.2 mn in 2014. Tags Paracetamol Manufacturing Plant, Paracetamol Production, Paracetamol Manufacturing, Paracetamol Manufacturing Process, Production of Paracetamol, Paracetamol Production Process, Manufacturing of Paracetamol Tablets, Paracetamol Manufacture in India, Manufacture of Paracetamol, Paracetamol Manufacturing Unit, Pharmaceutical Industry, Production Plant of Paracetamol, Pharmaceutical Manufacturing Business, Production Process of Paracetamol, Acetaminophen Manufacture, Manufacturing Plants of Paracetamol, Acetaminophen Manufacturing Plants, Industrial Production of Paracetamol, Business Plan for Acetaminophen Manufacturing, Paracetamol Manufacturing Business, Paracetamol Manufacturing Industry, Production of Acetaminophen Production Plant of Paracetamol, How to Prepare Paracetamol, Manufacturing and Formulation of Paracetamol, Paracetamol Manufacturing Project Report, Method for Manufacturing of Paracetamol, Method for Production of Paracetamol, Paracetamol Production Method, Manufacturing Method of Paracetamol, Production Plan for Paracetamol, Manufacturing Business of Paracetamol, Business Ideas for Manufacturing of Paracetamol, Small Scale Paracetamol Manufacturing Business Ideas & Opportunities, Process for Producing Paracetamol, Preparation Method for Paracetamol, Profitable Paracetamol Manufacturing Business, Start Production of Paracetamol, Paracetamol Manufacturing Process in India, How to Make Paracetamol, Method of Making Paracetamol, Drugs Manufacturing Project, Drugs Manufacturing Plant, Drugs Production, Paracetamol Manufacturing Project Ideas, Projects on Small Scale Industries, Small Scale Industries Projects Ideas, Paracetamol Manufacturing Based Small Scale Industries Projects, Project Profile on Small Scale Industries, How to Start Acetaminophen Manufacturing Industry in India, Paracetamol Manufacturing Projects, New Project Profile on Paracetamol Manufacturing Industries, Project Report on Acetaminophen Manufacturing Industry, Detailed Project Report on Paracetamol Production, Project Report on Paracetamol Manufacturing, Pre-Investment Feasibility Study on Paracetamol Manufacturing, Techno-Economic Feasibility Study on Paracetamol Manufacturing, Feasibility Report on Paracetamol Manufacturing, Free Project Profile on Paracetamol Production, Project Profile on Acetaminophen Manufacturing, Download Free Project Profile on Paracetamol Production, Industrial Project Report, Project Consultant, Project Consultancy, NPCS, Niir, Process Technology Books, Business Consultancy, Business Consultant, Project Identification and Selection, Preparation of Project Profiles, Startup, Business Guidance, Business Guidance to Clients, Startup Project for Paracetamol Manufacturing, Startup Project, Startup Ideas, Project for Startups, Startup Project Plan, Business Start-Up, Business Plan for Startup Business, Great Opportunity for Startup, Small Start-Up Business Project, Project Report for Bank Loan, Project Report for Bank Finance, Project Report Format for Bank Loan in Excel, Excel Format of Project Report and CMA Data, Project Report Bank Loan Excel, Detailed Project Plan Reports
Plant capacity: Paracetamol Tablets: 1500mt/annum Paracetamol Powder: 420mt/annumPlant & machinery: 349 Lakhs
Working capital: -T.C.I: 863 Lakhs
Return: 27.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Production of Paracetamol (Acetaminophen) Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

Paracetamol, also known as acetaminophen or APAP, is a medication used to treat pain and fever. It is typically used for mild to moderate pain. The quality of the evidence regarding the use for fever relief in children is poor. It is often sold in combination with other ingredients such as in many cold medications. In combination with opioid pain medication, paracetamol is used for more severe pain such as cancer pain and after surgery. It is typically used either by mouth or rectally but is also available intravenously. Effects last between two and four hours. Paracetamol lacks anti-inflammatory action in rheumatic disorders. However, it is less toxic than the Aspirin and does not produce anemia and liver damage, which sometimes result from the continued use of acetanilide and acetophenotidine. It is also an important intermediate in the manufacture of other pharmaceuticals like the antimalarial amodiaquine. Few Indian Major Players are as under: • Alta Laboratories Ltd. • Granules India Ltd. • HaffkineAjintha Pharmaceuticals Ltd. • Pan Drugs Ltd. Market Outlook The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in terms of value. 20% of global exports in generics, making it the largest provider of generic medicines globally. USD 45 Billion in revenue by 2020, revenue of USD 55 billion by 2020 as base case, and can grow to USD 70 billion in an aggressive case scenario. USD 26.1 Billion in generics by 2016. USD 200 Billion to be spent on infrastructure by 2024. Global acetaminophen market was valued at around USD 801.3 million in 2014 and is expected to reach USD 999.4 million in 2020, growing at a CAGR of around 3.8% between 2015 and 2020. In terms of volume, the global acetaminophen market stood at above 149.3 kilo tons in 2014. The global paracetamol market is expected to reach US$1,049.7 mn by 2022 as compared to its valuation of US$900.2 mn in 2014. Tags Paracetamol Manufacturing Plant, Paracetamol Production, Paracetamol Manufacturing, Paracetamol Manufacturing Process, Production of Paracetamol, Paracetamol Production Process, Manufacturing of Paracetamol Tablets, Paracetamol Manufacture in India, Manufacture of Paracetamol, Paracetamol Manufacturing Unit, Pharmaceutical Industry, Production Plant of Paracetamol, Pharmaceutical Manufacturing Business, Production Process of Paracetamol, Acetaminophen Manufacture, Manufacturing Plants of Paracetamol, Acetaminophen Manufacturing Plants, Industrial Production of Paracetamol, Business Plan for Acetaminophen Manufacturing, Paracetamol Manufacturing Business, Paracetamol Manufacturing Industry, Production of Acetaminophen Production Plant of Paracetamol, How to Prepare Paracetamol, Manufacturing and Formulation of Paracetamol, Paracetamol Manufacturing Project Report, Method for Manufacturing of Paracetamol, Method for Production of Paracetamol, Paracetamol Production Method, Manufacturing Method of Paracetamol, Production Plan for Paracetamol, Manufacturing Business of Paracetamol, Business Ideas for Manufacturing of Paracetamol, Small Scale Paracetamol Manufacturing Business Ideas & Opportunities, Process for Producing Paracetamol, Preparation Method for Paracetamol, Profitable Paracetamol Manufacturing Business, Start Production of Paracetamol, Paracetamol Manufacturing Process in India, How to Make Paracetamol, Method of Making Paracetamol, Drugs Manufacturing Project, Drugs Manufacturing Plant, Drugs Production, Paracetamol Manufacturing Project Ideas, Projects on Small Scale Industries, Small Scale Industries Projects Ideas, Paracetamol Manufacturing Based Small Scale Industries Projects, Project Profile on Small Scale Industries, How to Start Acetaminophen Manufacturing Industry in India, Paracetamol Manufacturing Projects, New Project Profile on Paracetamol Manufacturing Industries, Project Report on Acetaminophen Manufacturing Industry, Detailed Project Report on Paracetamol Production, Project Report on Paracetamol Manufacturing, Pre-Investment Feasibility Study on Paracetamol Manufacturing, Techno-Economic Feasibility Study on Paracetamol Manufacturing, Feasibility Report on Paracetamol Manufacturing, Free Project Profile on Paracetamol Production, Project Profile on Acetaminophen Manufacturing, Download Free Project Profile on Paracetamol Production, Industrial Project Report, Project Consultant, Project Consultancy, NPCS, Niir, Process Technology Books, Business Consultancy, Business Consultant, Project Identification and Selection, Preparation of Project Profiles, Startup, Business Guidance, Business Guidance to Clients, Startup Project for Paracetamol Manufacturing, Startup Project, Startup Ideas, Project for Startups, Startup Project Plan, Business Start-Up, Business Plan for Startup Business, Great Opportunity for Startup, Small Start-Up Business Project, Project Report for Bank Loan, Project Report for Bank Finance, Project Report Format for Bank Loan in Excel, Excel Format of Project Report and CMA Data, Project Report Bank Loan Excel, Detailed Project Plan Reports
Plant capacity: Paracetamol Tablets: 1500mt/annum Paracetamol Powder: 420mt/annumPlant & machinery: 349 Lakhs
Working capital: -T.C.I: 863 Lakhs
Return: 27.00%Break even: 46.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 15 of 20 | Total 199 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top